Tumor Markers Quality Requirements: Disclosures
Page Access:

  National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines Committee
for Use of Tumor Markers in Clinical Practice: Quality Requirements

These include all reported relationships within the previous 2 years that may be relevant to the guidelines document.

 

 

Grant

Other Research Support

Speakers Bureau

Honoraria

Expert Witness

Ownership Interest

Consultant Advisory Board

Institution Employer

Other Disclosures

Sturgeon

Significant (>$10K)/Other

None

None

None

Abbott Diagnostics; Bayer Diagnostics; Beckman Coulter; Becton Dickinson; DAKO Ltd; DPC; Roche; Tosoh Biosciences Ltd; Wallac Oy Ltd

None

None

None

None

None

Diamandis

Significant (>$10K)/Other

None

None

None

None

None

None

None

None

None

Hoffman

Significant (>$10K)/Other

None

None

None

None

None

None

None

None

None

Chan

Significant (>$10K)/Other

None

Abbott; Beckman

Ciphergen; Roche

None

None

None

None

None

Tosoh (consulting)

Ling Ch’ng

Significant (>$10K)/Other

None

 

None

None

None

None

None

None

None

None

Hammond

Significant (>$10K)/Other

None

None

None

None

None

None

None

None

None

Hayes

Significant (>$10K)

None

None

None

None

None

None

None

None

None

 

Other (less than 10K)

None

Immunicon; Glaxo Smith Kline; Wyeth Ayerst Genetics Institute; Pfizer; Novartis

None

None

None

None

Abraxis; American Biosciences; AviaraDx; Cytogen Corp; Monogram Bioscience; Pfizer; Precision Therapeutics Inc; Prudential Financial; QuatRx Pharm; Siemens Medical Solutions Diagnostics; SternCapture

None

None

Liotta

Significant (>$10K)/Other

None

None

None

None

None

None

Theranostics Health

None

None

Petricoin

Significant (>$10K)/Other

None

None

None

None

None

None

None

None

None

Schmitt

Significant (>$10K)/Other

None

American Diagnostics Inc; Epigenomics AG

None

None

None

None

None

None

None

Semmes

Significant (>$10K)/Other

None

None

None

None

None

None

None

None

None

Sölétormos

Significant (>$10K)/Other

None

None

None

None

None

None

None

None

None

Merwe

Significant (>$10K)/Other

None

None

None

None

None

None

None

None

None